A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Viola Chen, MD
Eikon Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Scientia Clinical Research Ltd
Randwick, New South Wales, Australia
Active, not recruiting - Mater Cancer Care Centre, Mater Misericordiae Limited
South Brisbane, Queensland, Australia
Catherine Shannon, MDRecruiting - Gold Coast Private Hospital
Southport, Queensland, Australia
Andrea Tazbirkova, MDNot, yet, recruiting - Macquarie University
Sydney, Queensland, Australia
Dhanusha Sabanathan, MDRecruiting - Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Wen Xu, MDRecruiting - Peninsula and South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia
Vinod Ganju, MDRecruiting
- Cross Cancer Institute
Edmonton, Alberta, Canada
Quincy Chu, MDRecruiting - Princess Margaret Cancer Centre-University Health Network
Toronto, Ontario, Canada
Amit Oza, MDRecruiting - Sunnybrook Research Institute
Toronto, Ontario, Canada
Rossanna Pezo, MDRecruiting
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Jundong Li, MDRecruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Cuizhi Geng, MDRecruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Huihui Li, MDRecruiting - Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Xian Wang, MDRecruiting - Chongqing University Cancer Hospital
Chongqing, China
LI Yongsheng, MDLi Rong, MDRecruiting - Fujian Cancer Hospital
Fuzhou, China
Wu Fan, MDRecruiting - Zhejiang Cancer Hospital
Hangzhou, China
Zhu Jianqing, MDRecruiting - Fudan University Shanghai Cancer Center
Shanghai, China
Jian Zhang, MDXiaohua Wu, MDRecruiting
- Righospitalet
Copenhagen, Denmark
Martin Hoejgaard, MDRecruiting
- Hospices Civils de Lyon - Chu Lyon Sud
Pierre-Bénite, Rhone, France
Gilles Freyer, MDRecruiting - Clcc François Baclesse
Caen, France
Melanie Dos Santos, MDRecruiting - Institut Gustave Roussy
Villejuif, France
Alexandra LEARY, MDRecruiting
- Cha Bundang Medical Center, Cha University
Seongnam-si, Gyeonggi-do, South Korea
Yong Wha Moon, MDRecruiting - Gachon University - Gil Medical Center
Incheon, Namdong-gu, South Korea
Young Saing Kim, MDRecruiting - Severance Hospital, Yonsei University Health System
Seoul, South Korea
Joo Hyuk Sohn, MDRecruiting
- Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain
Enrique Gallardo, MDRecruiting - Hospital Clinico San Carlos
Madrid, Madrid, Spain
Jorge Bartolome, MDRecruiting - Clínica Universidad de Navarra - Hospital
Pamplona, Navarre, Spain
Antonio Gonzalez, MDRecruiting - Hospital del Mar
Barcelona, Spain
Maria Martinez Garcia, MDRecruiting - Vall D'Hebron Institute of Oncology
Barcelona, Spain
Elena Garralda, MDRecruiting - Fundacion Md Anderson Cancer Center
Madrid, Spain
Raul Marquez, MDRecruiting - Start Madrid Fundación Jiménez Díaz
Madrid, Spain
Bernard Doger, MDRecruiting - Start-Ciocc Hm Sanchinarro Hospital
Madrid, Spain
Ramón Yarza, MDRecruiting - Universidad de Sevilla - Hospital Universitario Virgen Macarena
Seville, Spain
Luis De La Cruz Merino, MDRecruiting - Hospital Clinico Universitario de Valencia - Incliva
Valencia, Spain
Desamparados Roda, MDRecruiting
- the University of Arizona Cancer Center
Tucson, Arizona, United States
Alejandro Recio-Boiles, MDRecruiting - University of Arkansas Winthrop P. Rockefeller Cancer Institute
Little Rock, Arkansas, United States
Michael Birrer, MDRecruiting - Hoag Health Center Irvine
Irvine, California, United States
Withdrawn - University California Irvine
Irvine, California, United States
Withdrawn - Sharp Memorial Hospital
San Diego, California, United States
Withdrawn - University of California San Francisco (ucsf)
San Francisco, California, United States
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2023
- Primary completion
- 1 Jun 2027
- Completion
- 1 Dec 2027
- Last update posted
- 15 Jun 2026
- Registered enrollment
- 156
- Registry id
- NCT06253130
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.